KYN, the first metabolite of KP, can function as an endogenous ligand to activate the aryl hydrocarbon receptor (AhR) in an autocrine/paracrine fashion, and emerging evidence points toward the tumour-promoting role of KYN-mediated activation of the AhR [100,101]. The gene discussed is AHR; the disease is neoplasm.